Quanta Pharma SLU-PP-332 20mg x 60 tablets

£91.00

Description
Reviews (0)

Quanta Pharma SLU-PP-332 20mg x 60 Tablets

Quanta Pharma SLU-PP-332 20mg x 60 tablets represents a cutting-edge development in metabolic research compounds. This product contains SLU-PP–332, a selective estrogen receptor modulator (SERM) alternative designed for researchers investigating metabolic pathways, fat oxidation, and muscle preservation mechanisms. Each bottle contains 60 tablets of 20mg purity-verified compound, manufactured under strict laboratory conditions for clinical and research applications.

Key Features

High Purity Standard: Manufactured with 99.8%+ chemical purity for accurate research data
Precision Dosage: Each tablet contains exactly 20mg of SLU-PP-332 for consistent experimental variables
Bulk Research Supply: 60-tablet configuration supports extended study periods without interruption
Quality Assurance: Produced by Quanta Pharma under ISO-certified laboratory protocols
Stable Formulation: Tablet form ensures compound stability and prevents degradation during storage
Research Grade: Intended strictly for in vitro and animal model metabolic studies

Mechanism of Action

SLU-PP-332 functions as a potent agonist of the estrogen-related receptor alpha (ERRα). This specific receptor regulates mitochondrial biogenesis and oxidative metabolism. Activation of ERRα triggers a cascade of gene expression changes that mimic certain aspects of exercise physiology. The compound increases the expression of genes involved in fatty acid oxidation while simultaneously promoting mitochondrial density in muscle tissue. This dual action shifts cellular energy production toward fat utilization rather than glucose dependency. The mechanism bypasses traditional hormonal pathways, targeting metabolic regulators directly at the nuclear receptor level.

Research Benefits

Enhanced Fat Oxidation: Promotes significant increase in lipid metabolism rates in observed models
Muscle Preservation: Maintains lean tissue mass during caloric deficit simulations
Mitochondrial Biogenesis: Increases mitochondrial count and efficiency in skeletal muscle cells
Metabolic Rate Elevation: Raises baseline energy expenditure without stimulant activity
Glucose Regulation: Improves insulin sensitivity markers in metabolic dysfunction models
Endurance Simulation: Mimics exercise-induced adaptations without physical exertion

When to Use

This compound suits research projects focused on metabolic syndrome, obesity mechanisms, and muscle wasting conditions. Utilize SLU-PP-332 when studying alternative approaches to fat loss that bypass traditional adrenergic pathways. Ideal for investigations into exercise mimetics and metabolic enhancement without physical training variables. Appropriate for studies examining mitochondrial dysfunction and remediation strategies. Suitable for comparative analysis against traditional metabolic modulators.

Dosage Guidelines for Research

Standard Research Protocol: 10-20mg per day divided into two equal administrations
Cycle Duration: Typical studies run 4-8 weeks followed by assessment periods
Administration Method: Oral administration with controlled food intake variables
Monitoring Requirements: Regular metabolic panel testing and tissue analysis required
Adjustment Protocol: Dosage adjustments based on specific research endpoints and model response
Discontinuation: Gradual tapering recommended for studies requiring post-cycle observation